ABSTRACT
Postprandial blood ammonia levels were significantly higher in 22 patients with Alzheimer's disease than in 37 control subjects. In the Alzheimer group, fasting blood ammonia levels were significantly higher in patients whose EEGs showed triphasic waves than in patients without this change. The direction of change from fasting to postprandial blood ammonia levels was also significantly different between these two groups.
Subject(s)
Alzheimer Disease/blood , Ammonia/blood , Aged , Alcohol Amnestic Disorder/blood , Alzheimer Disease/physiopathology , Eating , Electroencephalography , Fasting , Female , Hospitalization , Humans , Male , Middle Aged , Schizophrenia/bloodABSTRACT
Patients with Alzheimer's disease (AD) and matched controls fasted for 24 hours, and serial glucose, pyruvate, lactate, beta-hydroxybutyrate, acetoacetate, insulin, and glucagon levels were measured. Patients with AD showed a glucose insulin correlation pattern over the 24 hours that differed from the control group. These differences may be secondary to weight loss or to other metabolic or nutritional factors affecting the AD patients.
Subject(s)
Alzheimer Disease/blood , Blood Glucose/metabolism , 3-Hydroxybutyric Acid , Acetoacetates/blood , Fasting , Humans , Hydroxybutyrates/blood , Insulin/blood , Lactates/blood , Pyruvates/bloodABSTRACT
The Sanifilippo syndrome is an inherited dementia caused by defective degradation of heparan sulfate. In the course of its catabolism the heparan sulfate polymer must be desulfated. Heparan sulfate sulfatase activity was demonstrated in homogenates of normal tissues and cultured skin fibroblasts, and in normal urine. This activity was found to be grossly depressed or absent in necropsy specimens of liver and spleen from two Sanfilippo patients. The heparan sulfate sulfatase activity was not demonstrable in urine from eleven, or cultured fibroblasts from four Sanfilippo patients. Activities of alpha-N-acetyl-glucosaminidase, the site of the metabolic defect in the Sanfilippo B variant were either normal or slightly elevated in the Sanfilippo tissues and cultured fibroblasts whereas the mean level in the urine of our Sanfilippo patients was about one-third of that encountered in control urines.
Subject(s)
Glycosaminoglycans/metabolism , Heparitin Sulfate/metabolism , Mucopolysaccharidoses/enzymology , Mucopolysaccharidosis III/enzymology , Acetylglucosaminidase/metabolism , Acetylglucosaminidase/urine , Fibroblasts/enzymology , Humans , Hydrogen-Ion Concentration , Liver/enzymology , Spleen/enzymology , Sulfatases/metabolism , Sulfatases/urine , Urine/enzymologyABSTRACT
This first child of non-Jewish parents had nystagmus at 4 months of age, bilateral cherry-red macular spots at 7 months of age, and hyperacusis at 8 months of age; the patient has deteriorated progressively following a clinical course typical of Tay-Sachs disease B variant. Total beta-N-acetylhexosaminidase assayed with 4-methylumbelliferyl-beta-glucosamine (4 MU GlcNAc) as substrate was within the normal range in plasma and cultured dermal fibroblasts and 2/3 the normal mean in leukocytes. The hexosaminidase A activity, assayed with the same substrate in plasma and cultured fibroblasts, approximated Tay-Sachs disease heterozygote levels; however, the activity of hexosaminidase A assayed with 4 MU Glc NAc-6-sulfate in the plasma, leukocytes, and cultured fibroblasts was less than 8, 2, and 1%, respectively of the control mean. This female infant with the B1 variant of Tay-Sachs disease demonstrated an earlier onset and more rapidly progressive course than was observed in 4 of the 5 previously reported patients with this Tay-Sachs disease variant.
Subject(s)
Tay-Sachs Disease/enzymology , beta-N-Acetylhexosaminidases/genetics , Female , Hexosaminidase A , Humans , Infant , Mutation , Tay-Sachs Disease/geneticsSubject(s)
Carbohydrate Metabolism, Inborn Errors/enzymology , Glycosaminoglycans/metabolism , Hydrolases/blood , Intellectual Disability/metabolism , Leukocytes/enzymology , Acid Phosphatase/blood , Child , Galactosidases/blood , Glucuronidase/blood , Hexosaminidases/blood , Humans , Sulfatases/bloodSubject(s)
Carbohydrate Metabolism, Inborn Errors/enzymology , Glycosaminoglycans/metabolism , Glycoside Hydrolases/analysis , Intellectual Disability/enzymology , Liver/enzymology , Mucopolysaccharidosis I/enzymology , Mucopolysaccharidosis I/genetics , Sulfatases/analysis , Acid Phosphatase/analysis , Acid Phosphatase/blood , Adolescent , Child , Child, Preschool , Fucose , Galactosidases/analysis , Galactosidases/blood , Glucuronidase/analysis , Glucuronidase/blood , Glycoside Hydrolases/blood , Hexosaminidases/blood , Humans , Hyaluronoglucosaminidase/analysis , Hyaluronoglucosaminidase/blood , Mannose , Sulfatases/bloodABSTRACT
Metachromatic leukodystrophy (MLD) is a rare inherited neurodegenerative disease associated with a defect in the catabolism of sulphatide (galactocerebroside-sulphate) which accumulates in the nervous system. MLD can be diagnosed biochemically by demonstrating deficiency in the activity of the enzyme arylsulphatase A (ASA) and an excess of sulphatide in urine and tissues. Clinically adult MLD may present as a schizophrenic-like psychosis, which typically develops years before the onset of neurologial signs which are not inevitable. Urinary ASA was investigated in 99 chronic hospitalized psychiatric patients (including 77 schizophrenics). Thirteen showed reduced ASA activity. Of the nine who were available for further study, only one evinced reduced ASA activity in other tissues (for example, leukocytes and cultured fibroblasts). However, there was no evidence of sulphatidurea with impaired sulphatide hydrolysis in his intact cultured fibroblasts. Therefore, he tested negative for MLD. This biochemical profile is known as pseudosulphatase deficiency. The possible relationship of pseudosulphatase deficiency to schizophrenic-like conditions is discussed.